Emma Children (AMC)

Amsterdam 1105 AZ

1 studies enrolling now · 1 studies all time

What they study most

Renal Allograft Recipients

Studies at this site

• A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications — Recruiting now